Buy or sell Synthetic Genomics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Synthetic Genomics Stock

Synthetic Genomics develops genomic-driven solutions to address global energy and environmental challenges.

About Synthetic Genomics Stock

Synthetic Genomics, Inc. develops and commercializes genomic-driven solutions to address global energy and environmental challenges. The company engages in synthesizing and programming DNA by developing and utilizing the technologies in synthetic genomics. It designs and develops microbes for industrial processes and environmental applications. The company also develops microbial cultivation technologies and monitoring approaches that reveal novel microorganisms, suites of new genes, and fermentation platforms for metabolic engineering of microbes for commercial bioenergy applications. In addition, it involves in designing advanced biofuels with properties compared to ethanol and biodiesel; harnessing photosynthetic organisms to produce value added products directly from sunlight and carbon dioxide; developing new biological solutions to enhance production and/or recovery rates of subsurface hydrocarbons; and developing high-yielding, disease resistant, and economic feedstocks. The company's solutions help in improving the production of energy, chemicals, and pharmaceuticals, as well as enable carbon sequestration and environmental remediation. Synthetic Genomics, Inc. was founded in 2005 and is based in La Jolla, California.

Funding History

December 2005$30.0M
October 2011$0
February 2013$10.0M

Management

Co - Founder

Juan Enriquez

Founder & CEO

J. Venter

Co - Founder & Board of Directors

David C. Kiernan

CTO

Jim Flatt

Co - Founder & Co - Chief Scientific Officer

Hamilton Smith

Principal Scientist, Foods Program

Michele Champagne

CFO

Joseph Mahler

VP, Bioinformatics

Toby Richardson

Science Consultant

James Ferry

SVP, Business Development

Fernanda Gandara

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Synthetic Genomics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo